Clinical Research Coordinators H-1B visa sponsorship in Delaware: $143,337 avg salary ($52,704-$199,597). 86% approval rate.
In Delaware, there have been 6 H-1B filings for Clinical Research Coordinators positions, with an average salary of $143k. The top sponsors include IQVIA RDS Inc. (43%), ND Global Consulting Services Inc. (14%), Alexion Pharmaceuticals, Inc. (14%). 86% of petitions are certified. Salaries range from $53k to $200k.
| Total Filings | 7 |
| Approval Rate | 86% |
| Average Salary | $143,337 |
| Median Salary | $140,712 |
| 25th Percentile | $131,820 |
| 75th Percentile | $198,307 |
| Minimum Salary | $52,704 |
| Maximum Salary | $199,597 |
| Percentile | Salary |
|---|---|
| 10th | $53k |
| 25th | $132k |
| 50th (Median) | $141k |
| 75th | $198k |
| 90th | $200k |
Based on 6 salary records. Range: $53k – $200k.
67% of filings offer salaries above the prevailing wage, with an average premium of 18.8%. The average prevailing wage is $126k (based on 6 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 2 days, slowest: 10 days. Based on 6 filings.
57% of filings are for new positions, while 0% are for continued employment (7 filings with data).
Average contract duration: 36 months (median: 36 months), based on 7 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 7 |
| Employer | Filings | Avg Salary |
|---|---|---|
| IQVIA RDS Inc. | 3 | $134k |
| ND Global Consulting Services Inc. | 1 | $200k |
| Alexion Pharmaceuticals, Inc. | 1 | $198k |
| Spark Therapeutics, Inc | 1 | $141k |
| UNIVERSITY OF DELAWARE | 1 | $53k |
The average H-1B salary for Clinical Research Coordinators in Delaware is $143,337, with a median of $140,712. Salaries range from $52,704 to $199,597 across 7 filings.
Top sponsors for Clinical Research Coordinators in Delaware include Iqvia Rds INC. (3 filings), ND Global Consulting Services Inc. (1 filings), Alexion Pharmaceuticals, Inc. (1 filings).
The H-1B approval rate for Clinical Research Coordinators in Delaware is 86% across 7 DOL filings.